Anis Chaudhary | Biological Sensors | Research Excellence Award

Posted on by Global Sensor Awards

Research Excellence Award

Anis Chaudhary
Affiliation Imam Mohammad Ibn Saud Islamic University
Country Saudi Arabia
Scopus ID 57430001700
Documents 5
Citations 128
h-index 5
Subject Area Biological Sensors
Event Global Sensor Awards
ORCID 0000-0002-1506-7836

Anis Chaudhary
Imam Mohammad Ibn Saud Islamic University

The Research Excellence Award article presents an academic overview of Anis Chaudhary, a researcher affiliated with Imam Mohammad Ibn Saud Islamic University, Saudi Arabia. His scholarly profile reflects research activities in the field of biological sensors with publications indexed in Scopus, citation impact, and international academic visibility. The information presented here summarizes publicly available scholarly indicators together with an overview of research interests, scientific contributions, and relevance to recognition within the Global Sensor Awards.[1]

Abstract

Anis Chaudhary has contributed to biological sensor research through peer-reviewed publications emphasizing analytical sensing technologies, biosensing methodologies, and interdisciplinary scientific applications. Bibliometric indicators demonstrate measurable scholarly influence, including five indexed publications, 128 citations, and an h-index of five. These metrics illustrate sustained academic engagement and provide quantitative evidence of research visibility within the international scientific community.[1]

Keywords

  • Biological Sensors
  • Biosensing
  • Sensor Technology
  • Biomedical Engineering
  • Analytical Science
  • Research Excellence Award

Introduction

Biological sensors represent an important area of interdisciplinary research by integrating biology, chemistry, electronics, and materials science to develop systems capable of detecting biochemical signals with high sensitivity and specificity. Researchers working in this field contribute to healthcare diagnostics, environmental monitoring, food safety, and industrial quality assurance. Academic recognition within this discipline considers publication quality, citation performance, innovation, and broader scientific influence.[2]

Research Profile

The research profile of Anis Chaudhary reflects scholarly activity centered on biological sensing technologies and related analytical applications. Affiliated with Imam Mohammad Ibn Saud Islamic University, the researcher has established an indexed publication record with measurable citation performance. Such bibliometric indicators provide an objective framework for evaluating scientific productivity and research influence across international databases.[1]

Research Contributions

  • Contributions to biological sensing methodologies.
  • Participation in interdisciplinary sensor research.
  • Development of scientific knowledge through peer-reviewed publications.
  • Support for biomedical and analytical sensing applications.
  • International dissemination of research findings through indexed literature.

Publications

According to the Scopus author profile, the researcher has published five indexed documents that have collectively received 128 citations. These publications contribute to the advancement of biological sensor research and demonstrate continued participation in scholarly communication.[1]

  • Indexed publications in biological sensor research.
  • Citation-supported scientific contributions.
  • Research outputs accessible through international indexing services.

Research Impact

Bibliometric measures such as citation counts and the h-index are commonly used indicators for evaluating academic influence. The available metrics indicate that the researcher’s work has attracted scholarly attention and has contributed to ongoing developments in biological sensing technologies. These indicators support evidence-based assessment of scientific productivity and research visibility.[1]

Award Suitability

Based on publicly available scholarly indicators, Anis Chaudhary demonstrates characteristics commonly evaluated for research recognition, including peer-reviewed publications, citation performance, subject specialization, and international academic visibility. These measurable achievements align with the objectives of the Global Sensor Awards in recognizing noteworthy contributions to sensor science and technology while maintaining an evidence-based assessment approach.[3]

Conclusion

This article provides a structured academic overview of Anis Chaudhary and summarizes key bibliometric information, institutional affiliation, and research specialization. The profile reflects continued engagement in biological sensor research and highlights objective scholarly indicators that are useful for academic recognition, professional evaluation, and international research visibility.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Anis Chaudhary, Author ID 57430001700. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57430001700
  2. Nature Reviews Materials. (2019). Advances in biosensors and analytical sensing technologies.DOI: https://doi.org/10.1038/s41578-019-0145-6
  3. Global Sensor Awards. (n.d.). International Recognition for Excellence in Sensor Research.

Ziyi Zhou | Biological Sensors | Best Researcher Award

Posted on by Global Sensor Awards

Best Researcher Award

Ziyi Zhou
Jiangxi Medical College, Nanchang University, China
Ziyi Zhou
Affiliation Jiangxi Medical College, Nanchang University
Country China
Documents 2
Subject Area Oncology, Tumor Biology, Exosome Research, Biological Sensors Environmental Carcinogenesis
Event Global Sensor Awards
ORCID 0009-0000-6766-3405

Ziyi Zhou is a postgraduate researcher in Oncology at Jiangxi Medical College, Nanchang University, whose academic work focuses on tumor microenvironment biology, exosome-mediated immune regulation, and the emerging role of microplastics in lung cancer pathogenesis. His educational and clinical training encompasses medicine, general practice, and oncology research. Through interdisciplinary investigations combining molecular oncology, environmental health sciences, and translational medicine, Zhou has contributed to understanding mechanisms of cancer progression and immune dysfunction. His research outputs include peer-reviewed publications, international conference presentations, and nationally recognized scientific communication initiatives.[1]

Abstract

This academic profile summarizes the educational background, clinical experience, research activities, and scholarly contributions of Ziyi Zhou. His work centers on molecular oncology, exosome biology, immune regulation, and environmental carcinogenesis. His published research identified a novel Aurora A-mediated exosomal signaling mechanism associated with T-lymphocyte apoptosis, while his ongoing investigations explore the presence and biological significance of microplastics in lung cancer tissues. Through conference presentations, peer-reviewed publication, and professional society participation, Zhou has demonstrated a growing contribution to contemporary cancer research and translational oncology.[1]

Keywords

Oncology; Tumor Microenvironment; Exosomes; Aurora A Kinase; T-Lymphocyte Apoptosis; Microplastics; Lung Adenocarcinoma; Environmental Carcinogenesis; Immune Regulation; Translational Medicine; NSCLC; Cancer Biology.

Introduction

Ziyi Zhou completed a Bachelor of Medicine degree from Gannan Medical University between 2013 and 2018 before undertaking standardized residency training in General Practice at the Affiliated Hospital of Jinggangshan University. Following clinical service as an attending physician, he transitioned into oncology-focused postgraduate research at Jiangxi Medical College, Nanchang University. This progression from clinical medicine to scientific investigation has enabled him to integrate patient-centered perspectives with mechanistic cancer research.[2]

Research Profile

Zhou’s primary research interests encompass tumor microenvironment dynamics, exosome-mediated signaling pathways, immune cell regulation, and environmental factors contributing to cancer development. His studies explore how cellular communication mechanisms influence disease progression and therapeutic outcomes. Recent work has also examined microplastic accumulation within pulmonary tumor tissues, contributing to a rapidly developing field investigating environmental contaminants and human health risks.[1]

  • Master’s candidate in Oncology at Jiangxi Medical College, Nanchang University.
  • Former attending physician in general practice.
  • Member of ESMO, CACA, and CSCO.
  • Presenter at ESMO Asia 2025 and national scientific meetings.
  • Research focus on cancer immunology and environmental oncology.

Research Contributions

One of Zhou’s notable contributions is the identification of an Aurora A-mediated mechanism that promotes exosomal secretion of miR-644a and subsequently induces T-lymphocyte apoptosis through the NOXA/p4E-BP1/MCL-1 signaling pathway. This work contributes to a broader understanding of tumor-associated immune suppression and provides insight into molecular pathways relevant to cancer progression.[1]

In addition, he conducted pioneering investigations into microplastic occurrence within peritumoral and tumor tissues of lung adenocarcinoma. These findings have generated interest in environmental exposures as potential contributors to carcinogenesis and disease progression. His systematic review and meta-analysis evaluating concurrent versus sequential chemoradiotherapy combined with immune checkpoint inhibitors in non-small-cell lung cancer further demonstrates his engagement with evidence-based oncology research.[3]

Publications

  • Zhou Z., Chen B., Zheng K., Wan D., and Kuang P. (2026). Aurora A-Mediated Exosomal Secretion of miR-644a Promotes T-Lymphocyte Apoptosis Through the NOXA/p4E-BP1/MCL-1 Pathway. Clinical and Experimental Pharmacology and Physiology, 53(6), e70132.
  • Characterization and Evaluation of Microplastics in Peritumoral and Tumor Tissues of Lung Adenocarcinoma. Poster Presentation, ESMO Asia Congress 2025.
  • Systematic Review and Meta-analysis of Concurrent versus Sequential Chemoradiotherapy Combined with Immune Checkpoint Inhibitors in NSCLC. National Conference Poster Presentation, 2025.

Research Impact

Although still at an early stage of his research career, Zhou’s work has demonstrated scientific relevance in both molecular and environmental oncology. His publication in a PubMed-indexed journal, participation in international conferences, and interdisciplinary approach illustrate an emerging research profile. Furthermore, his science communication activities addressing microplastics and cancer risk have contributed to public awareness and community engagement in cancer prevention topics.[1]

Award Suitability

Ziyi Zhou demonstrates several characteristics consistent with consideration for a Best Researcher Award nomination. These include original scientific contributions, interdisciplinary research engagement, publication in peer-reviewed international literature, active participation in professional societies, conference dissemination, and commitment to addressing emerging public health concerns. His combination of clinical experience and laboratory-based investigation provides a foundation for continued contributions to oncology and translational medical research.[1]

Conclusion

The academic profile of Ziyi Zhou reflects a developing researcher with expertise spanning medicine, oncology, immunology, and environmental health sciences. His work on exosome-mediated immune regulation and microplastic-associated carcinogenesis contributes to contemporary scientific discussions regarding cancer biology and disease prevention. Continued research activities and scholarly dissemination are expected to strengthen his impact within the field of oncology.

References

  1. Zhou, Z., Chen, B., Zheng, K., Wan, D., & Kuang, P. (2026). Aurora A-Mediated Exosomal Secretion of miR-644a Promotes T-Lymphocyte Apoptosis Through the NOXA/p4E-BP1/MCL-1 Pathway. Clinical and Experimental Pharmacology and Physiology, 53(6), e70132.https://doi.org/10.1111/1440-1681.70132
  2. ORCID. (2026). Ziyi Zhou – ORCID Record.https://orcid.org/0009-0000-6766-3405
  3. European Society for Medical Oncology (ESMO). (2025). ESMO Asia Congress Scientific Presentation Records.https://www.esmo.org

Dr. Zheng Hu | Biosensor Awards | Best Researcher Award

Posted on by Global Sensor Awards

Dr. Zheng Hu | Biosensor Awards | Best Researcher Award

Dr. Zheng Hu, University of Chinese Academy of Sciences , Beijing, China

Dr. Zheng Hu is an Associate Professor and Deputy Director at the Translational Medicine Institute of South China University, based at The First People’s Hospital of Chenzhou, Hunan, China. With a Ph.D. in Biochemistry and Molecular Biology from the University of Chinese Academy of Sciences, his research focuses on gene editing technology, cancer biomarkers, and screening of anti-tumor compounds from traditional Chinese herbs. He has made significant contributions to cancer screening and nucleic acid detection, with several publications in high-impact journals. Dr. Hu is also recognized for his work on CRISPR-based detection systems and molecular pathogenesis in various cancers.

Professional Profile:

Orcid

Summary of Suitability:

Dr. Zheng Hu is an outstanding candidate for the Best Researcher Award due to his prolific research contributions, particularly in gene editing and cancer biomarker development. His innovative approach to applying cutting-edge technologies like CRISPR in clinical settings, along with his strong publication record and leadership, makes him highly deserving of recognition. His research has the potential to revolutionize cancer diagnostics and treatments, underscoring his impact in the biomedical field.

🎓Education:

Dr. Zheng Hu earned his Ph.D. in Biochemistry and Molecular Biology from the University of Chinese Academy of Sciences in Beijing, China, between 2011 and 2014. Prior to that, he completed his M.S. in Genetics from Xiangya Medical School of Central South University in Changsha, China, from 2001 to 2005. He also holds a B.S. in Biology, which he obtained from the School of Life Science at Central China Normal University in Wuhan, China, during 1994 to 1998.

🏢Work Experience:

Dr. Zheng Hu has held the position of Associate Professor at the Translational Medicine Institute of South China University, located at The First People’s Hospital of Chenzhou, Hunan, China, since 2018. Prior to this role, he worked as a Postdoctoral Research Fellow at Xiangya Hospital, Central South University, in Changsha, from 2015 to 2018. Between 2014 and 2015, Dr. Hu served as an Assistant Investigator at the same institute where he is now a professor. He also worked as an Assistant Investigator at the Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, from 2010 to 2011, and as a Research Associate at the same institute from 2005 to 2010. Earlier in his career, between 1998 and 2001, he was a Technician and Teaching Assistant at Xiangya Medical School of Central South University in Changsha.

🏅Awards and Honors:

Dr. Zheng Hu is recognized for his significant contributions to the development of CRISPR-based detection systems and cancer biomarker research. He has published extensively in high-impact journals, earning recognition for his advancements in cancer screening and gene editing technology. His work has greatly influenced the fields of translational medicine and molecular biology, showcasing innovative approaches to cancer detection and treatment.

Publication Top Notes:

  1. Targeted disruption of the BCR-ABL fusion gene by Cas9/dual-sgRNA inhibits proliferation and induces apoptosis in chronic myeloid leukemia cells
  2. Rapid, portable Epstein‒Barr virus DNA detection using enzymatic recombinase amplification combined with the CRISPR–Cas12a system
  3. CRISPR/Cas13a-based supersensitive circulating tumor DNA assay for detecting EGFR mutations in plasma
  4. SARS-CoV-2 and Its Omicron Variants Detection with RT-RPA-CRISPR/Cas13a-Based Method at Room Temperature
  5. Stabilization of UCA1 by N6-methyladenosine RNA methylation modification promotes colorectal cancer progression